Abstract
An important aspect of enzymatic assays is that the effect of a ligand on enzyme activity is readily apparent and quantifiable. Enzyme-based assays are, therefore, highly amenable to high-throughput ligand screening, which profiles the effect of a panel of small molecules on a designated target. In order for enzyme assays to provide useful screening data, the kinetics, assay components, readout signal, and overall stability of the assay are optimized and adapted to the equipment prior to the screen. For the screen itself, careful consideration is given to the number of replicates, the plate layout, the compound concentration, and the details of assay assembly. Lastly, in the post-screen stages, the ligand screening data is processed and analyzed using various strategies, and the resulting preliminary hits are subjected to a series of secondary and tertiary assays to eliminate false positives and poor quality hits. The various stages of screening are described, using a viral protease, NS3/4A from Hepatitis C virus, as an example of an enzyme target.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dove A (2007) High-throughput screening goes to school. Nat Methods 4:523–532
Zheng CJ, Han LY, Yap CW et al (2006) Therapeutic targets: progress of their exploration and investigation of their characteristics. Pharmacol Rev 58:259–279
Goddard JP, Reymond JL (2004) Enzyme assays for high-throughput screening. Curr Opin Biotechnol 15:314–322
Taliani M, Bianchi E, Narjes F et al (1996) A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal Biochem 240(1):60–67
Copeland RA (2005) Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. Methods Biochem Anal 46:1–265
Macarron R, Hertzberg RP (2011) Design and implementation of high throughput screening assays. Mol Biotechnol 3:270–285
Johnston PA, Foster CA, Shun TY et al (2007) Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors. Assay Drug Dev Technol 5:319–332
Tierno MB, Johnston PA, Foster C et al (2007) Development and optimization of high-throughput in vitro protein phosphatase screening assays. Nat Protoc 2:1134–1144
Feng BY, Shoichet BK (2006) A detergent-based assay for the detection of promiscuous inhibitors. Nat Protoc 1:550–553
Lu H, England K, am Ende C et al (2009) Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity. ACS Chem Biol 4(3):221–231
Zhang JH, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67–73
Wu Z, Liu D, Sui Y (2008) Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings. J Biomol Screen 13(2):159–167
Malo N, Hanley JA, Cerquozzi S et al (2006) Statistical practice in high-throughput screening data analysis. Nat Biotechnol 24(2):167–175
Walters WP, Stahl MT, Murcko MA (1998) Virtual screening: an overview. Drug Discovery Today 3(4):160–178
Walters WP, Namchuk M (2003) Designing screens: how to make your hits a hit. Nat Rev Drug Discov 2(4):259–266
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ratia, K., Mehboob, S., Lee, H. (2014). Ligand Screening Using Enzymatic Assays. In: Anderson, W.F. (eds) Structural Genomics and Drug Discovery. Methods in Molecular Biology, vol 1140. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-0354-2_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0354-2_21
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-0353-5
Online ISBN: 978-1-4939-0354-2
eBook Packages: Springer Protocols